Benefits payments have been handed out to people with conditions including obesity, acne, writer's cramp and alcoholism.

A Cambridge biotech company is preparing to lay off its entire staff of more than 300 after being acquired by another firm.

The FDA now requires updated labeling for all extended-release stimulant medications used to treat attention deficit hyperactivity disorder, warning of increased risk of weight loss and other side ...

The latest "Adult Psychiatric Morbidity Survey" (APMS), published by NHS England, shows a sharp rise in mental health issues ...

Telehealth prescribing of stimulants for teens and adults with ADHD is not linked to a higher risk for substance use disorder vs in-person prescribing, a new study shows.

Scientists and public health advocates see disconnects between what the Trump administration says about health — notably, in ...

Jeremy Didier had taken her son to a psychologist for a possible ADHD evaluation when she spotted an article about women with ...

ADHD Advisor examines why ADHD often goes undiagnosed in women and girls, and how gender biases in symptoms and diagnosis ...

The Food and Drug Administration is revising the labeling of all extended-release stimulants used to treat attention-deficit ...

Children younger than 6 years of age who are prescribed extended-release stimulants for attention-deficit hyperactivity disorder (ADHD) may experience higher rates of adverse reactions due to higher ...

Notice of the Cambridge biotech's layoffs came less than two weeks after Sage announced it would be acquired by ...